Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
Primary:
·To evaluate the activity of the combination of gemcitabine, oxaliplatin and vinorelbine as
first line treatment in patients with non-small cell bronchopulmonary cancer
Secondary:
·To evaluate the toxicity of the combination